Abstract
Carbohydrate post-translational modifications on proteins are important determinants of protein function in both normal and disease biology. We have developed a method to allow the efficient, multiplexed study of glycans on individual proteins from complex mixtures, using antibody microarray capture of multiple proteins followed by detection with lectins or glycan-binding antibodies. Chemical derivatization of the glycans on the spotted antibodies prevented lectin binding to those glycans. Multiple lectins could be used as detection probes, each targeting different glycan groups, to build up lectin binding profiles of captured proteins. By profiling both protein and glycan variation in multiple samples using parallel sandwich and glycan-detection assays, we found cancer-associated glycan alteration on the proteins MUC1 and CEA in the serum of pancreatic cancer patients. Antibody arrays for glycan detection are highly effective for profiling variation in specific glycans on multiple proteins and should be useful in diverse areas of glycobiology research.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT)
Communications Biology Open Access 30 October 2020
-
Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer
Journal of Nanobiotechnology Open Access 22 October 2020
-
A novel glycosidase plate-based assay for the quantification of galactosylation and sialylation on human IgG
Glycoconjugate Journal Open Access 16 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Dube, D.H. & Bertozzi, C.R. Glycans in cancer and inflammation–potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4, 477–488 (2005).
Dennis, J.W., Granovsky, M. & Warren, C.E. Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1473, 21–34 (1999).
Fuster, M.M. & Esko, J.D. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526–542 (2005).
van Dijk, W., Havenaar, E.C. & Brinkman-van der Linden, E.C. Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconj. J. 12, 227–233 (1995).
Okuyama, N. et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803–2808 (2006).
Thompson, S., Stappenbeck, R. & Turner, G.A. A multiwell lectin-binding assay using lotus tetragonolobus for measuring different glycosylated forms of haptoglobin. Clin. Chim. Acta 180, 277–284 (1989).
Kuno, A. et al. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat. Methods 2, 851–856 (2005).
Pilobello, K.T., Krishnamoorthy, L., Slawek, D. & Mahal, L.K. Development of a lectin microarray for the rapid analysis of protein glycopatterns. ChemBioChem 6, 985–989 (2005).
Zheng, T., Peelen, D. & Smith, L.M. Lectin arrays for profiling cell surface carbohydrate expression. J. Am. Chem. Soc. 127, 9982–9983 (2005).
Shimizu, K. et al. Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis. Clin. Chim. Acta 254, 23–40 (1996).
Thompson, S., Cantwell, B.M., Cornell, C. & Turner, G.A. Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis. Br. J. Cancer 64, 386–390 (1991).
Thompson, S., Guthrie, D. & Turner, G.A. Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer. Br. J. Cancer 58, 589–593 (1988).
Kjeldsen, T. et al. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 48, 2214–2220 (1988).
Hanisch, F.G., Hanski, C. & Hasegawa, A. Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Cancer Res. 52, 3138–3144 (1992).
Burchell, J. et al. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47, 5476–5482 (1987).
Hirabayashi, J. et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572, 232–254 (2002).
Van Damme, E.J.M., Peumans, W.J., Pusztai, A. & Bardocz, S. Handbook of Plant Lectins: Properties and Biomedical Applications (John Wiley & Sons, Chichester, 1998).
Manimala, J.C., Roach, T.A., Li, Z. & Gildersleeve, J.C. High-throughput carbohydrate microarray analysis of 24 lectins. Angew. Chem. Int. Edn Engl. 45, 3607–3610 (2006).
Roberts, G.P. Histochemical detection of sialic acid residues using periodate oxidation. Histochem. J. 9, 97–102 (1977).
Yamashita, K., Koide, N., Endo, T., Iwaki, Y. & Kobata, A. Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J. Biol. Chem. 264, 2415–2423 (1989).
Reis, C.A., David, L., Seixas, M., Burchell, J. & Sobrinho-Simoes, M. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int. J. Cancer 79, 402–410 (1998).
Lloyd, K.O., Burchell, J., Kudryashov, V., Yin, B.W. & Taylor-Papadimitriou, J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 271, 33325–33334 (1996).
Ho, J.J., Siddiki, B. & Kim, Y.S. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin in a pancreatic cancer cell line. Cancer Res. 55, 3659–3663 (1995).
Kalthoff, H., Kreiker, C., Schmiegel, W.H., Greten, H. & Thiele, H.G. Characterization of CA 19–9 bearing mucins as physiological exocrine pancreatic secretion products. Cancer Res. 46, 3605–3607 (1986).
von Ritter, C. et al. Biliary mucin secreted by cultured human gallbladder epithelial cells carries the epitope of CA 19–9. Anticancer Res. 17, 2931–2934 (1997).
Lucka, L. et al. Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiology 15, 87–100 (2005).
Stocks, S.C., Albrechtsen, M. & Kerr, M.A. Expression of the CD15 differentiation antigen (3-fucosyl-N-acetyl-lactosamine, LeX) on putative neutrophil adhesion molecules CR3 and NCA-160. Biochem. J. 268, 275–280 (1990).
Stocks, S.C. & Kerr, M.A. Neutrophil NCA-160 (CD66) is the major protein carrier of selectin binding carbohydrate groups LewisX and sialyl lewisX. Biochem. Biophys. Res. Commun. 195, 478–483 (1993).
Blixt, O. et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101, 17033–17038 (2004).
Manimala, J.C., Li, Z., Jain, A., VedBrat, S. & Gildersleeve, J.C. Carbohydrate array analysis of anti-Tn antibodies and lectins reveals unexpected specificities: implications for diagnostic and vaccine development. ChemBioChem 6, 2229–2241 (2005).
Acknowledgements
We thank D. Mistry for assistance with the experiments and other members of the Laboratory of Cancer Immunodiagnostics at the Van Andel Research Institute for helpful interactions. We thank A. Rai (Memorial Sloan Kettering Cancer Center) and I. Goldstein (University of Michigan) for valuable input. We gratefully acknowledge the Van Andel Research Institute for support of this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.B.H. and S.C. are inventors on a patent application covering the technology described in this article. This technology has been licensed for commercialization by GenTel Biosciences (Madison, Wisconsin, USA).
Supplementary information
Supplementary Fig. 1
Chemical derivatization of antibodies to block lectin binding. (PDF 507 kb)
Supplementary Fig. 2
Optimization of antibody derivatization. (PDF 4163 kb)
Supplementary Fig. 3
Optimization of NaIO4 oxidation. (PDF 509 kb)
Supplementary Fig. 4
Effects of NaIO4 concentration on antibody retainment and background signals. (PDF 532 kb)
Supplementary Table 1
Lectins used in the experiments and their specificities. (PDF 133 kb)
Supplementary Table 2
Measured EC50s of 24 lectins for the glycans of spotted antibodies. (PDF 531 kb)
Supplementary Table 3
Antibodies and proteins used in the experiments. (PDF 21 kb)
Rights and permissions
About this article
Cite this article
Chen, S., LaRoche, T., Hamelinck, D. et al. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat Methods 4, 437–444 (2007). https://doi.org/10.1038/nmeth1035
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth1035
This article is cited by
-
Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer
Journal of Nanobiotechnology (2020)
-
Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT)
Communications Biology (2020)
-
Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoforms
Glycoconjugate Journal (2020)
-
A novel glycosidase plate-based assay for the quantification of galactosylation and sialylation on human IgG
Glycoconjugate Journal (2020)
-
Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns
Clinical Proteomics (2018)